S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.42 (+1.84%)
AAPL   111.70 (+1.47%)
MSFT   207.55 (+2.47%)
FB   254.39 (+2.51%)
GOOGL   1,459.85 (+2.08%)
AMZN   3,129.00 (+5.69%)
NVDA   504.25 (+0.71%)
TSLA   421.54 (-6.20%)
BABA   274.75 (+0.34%)
CGC   16.04 (+1.91%)
GE   6.24 (-1.73%)
MU   49.69 (+1.10%)
AMD   77.67 (-0.35%)
T   28.53 (-0.35%)
F   6.78 (-1.31%)
ACB   7.43 (+17.56%)
GILD   63.48 (-1.14%)
NFLX   490.92 (+0.73%)
DIS   127.40 (+1.59%)
BAC   23.93 (-2.21%)
BA   156.85 (+0.32%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.42 (+1.84%)
AAPL   111.70 (+1.47%)
MSFT   207.55 (+2.47%)
FB   254.39 (+2.51%)
GOOGL   1,459.85 (+2.08%)
AMZN   3,129.00 (+5.69%)
NVDA   504.25 (+0.71%)
TSLA   421.54 (-6.20%)
BABA   274.75 (+0.34%)
CGC   16.04 (+1.91%)
GE   6.24 (-1.73%)
MU   49.69 (+1.10%)
AMD   77.67 (-0.35%)
T   28.53 (-0.35%)
F   6.78 (-1.31%)
ACB   7.43 (+17.56%)
GILD   63.48 (-1.14%)
NFLX   490.92 (+0.73%)
DIS   127.40 (+1.59%)
BAC   23.93 (-2.21%)
BA   156.85 (+0.32%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.42 (+1.84%)
AAPL   111.70 (+1.47%)
MSFT   207.55 (+2.47%)
FB   254.39 (+2.51%)
GOOGL   1,459.85 (+2.08%)
AMZN   3,129.00 (+5.69%)
NVDA   504.25 (+0.71%)
TSLA   421.54 (-6.20%)
BABA   274.75 (+0.34%)
CGC   16.04 (+1.91%)
GE   6.24 (-1.73%)
MU   49.69 (+1.10%)
AMD   77.67 (-0.35%)
T   28.53 (-0.35%)
F   6.78 (-1.31%)
ACB   7.43 (+17.56%)
GILD   63.48 (-1.14%)
NFLX   490.92 (+0.73%)
DIS   127.40 (+1.59%)
BAC   23.93 (-2.21%)
BA   156.85 (+0.32%)
S&P 500   3,315.57 (+1.05%)
DOW   27,288.18 (+0.52%)
QQQ   272.42 (+1.84%)
AAPL   111.70 (+1.47%)
MSFT   207.55 (+2.47%)
FB   254.39 (+2.51%)
GOOGL   1,459.85 (+2.08%)
AMZN   3,129.00 (+5.69%)
NVDA   504.25 (+0.71%)
TSLA   421.54 (-6.20%)
BABA   274.75 (+0.34%)
CGC   16.04 (+1.91%)
GE   6.24 (-1.73%)
MU   49.69 (+1.10%)
AMD   77.67 (-0.35%)
T   28.53 (-0.35%)
F   6.78 (-1.31%)
ACB   7.43 (+17.56%)
GILD   63.48 (-1.14%)
NFLX   490.92 (+0.73%)
DIS   127.40 (+1.59%)
BAC   23.93 (-2.21%)
BA   156.85 (+0.32%)
Log in
LON:HNT

Huntsworth Share Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range
107.50
MA: GBX 873.10
2,500
52-Week Range N/A
Volume1,685 shs
Average Volume72,421 shs
Market Capitalization£399.60 million
P/E Ratio20.00
Dividend Yield2.42%
BetaN/A
Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams. This division serves pharmaceutical and biotechnology clients. The Marketing division markets prescription drugs to consumers and healthcare professionals; and provides healthcare public relations agency and payer marketing services. This segment serves biotech and pharma, OTC, wellness, and lifestyle brands. The Immersive division creates and delivers live experiences, and scientific and interactive contents; creates and produces various films, including short and internal engagement films, documentaries, and action demonstrations; develops immersive experiences for employees training and explaining complex science; and designs strategic and creative programs to engage internal audiences. This division primarily serves healthcare industry. The Communications division provides public relations and affairs, and investor relations solutions; and communication consulting services primarily for cross-border financial transactions and multinationals to broaden their global footprint, as well as develops and manages campaigns, runs press offices, and steers brands and businesses through engagement with media, consumers, customer stakeholders, and internal audiences. The company was formerly known as Holmes & Marchant Group plc and changed its name to Huntsworth plc in July 1999. Huntsworth plc was incorporated in 1983 and is headquartered in London, the United Kingdom.
Read More
Huntsworth logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.66 out of 5 stars


Industry, Sector and Symbol

Industry Advertising Agencies
Sub-IndustryN/A
SectorServices
CUSIPN/A
CIKN/A
Phone+44-20-72248778

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales£264.85 million
Book ValueGBX 49.80 per share

Profitability

Miscellaneous

Employees1,903
Market Cap£399.60 million
Next Earnings DateN/A
OptionableNot Optionable
30 days | 90 days | 365 days | Advanced Chart

Receive HNT News and Ratings via Email

Sign-up to receive the latest news and ratings for HNT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Huntsworth (LON:HNT) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Huntsworth?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Huntsworth in the last year. There are currently 3 hold ratings, 1 buy rating and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Huntsworth
.

How were Huntsworth's earnings last quarter?

Huntsworth plc (LON:HNT) posted its quarterly earnings results on Tuesday, July, 24th. The company reported $2.60 earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of $2.80 by $0.20.
View Huntsworth's earnings history
.

How often does Huntsworth pay dividends? What is the dividend yield for Huntsworth?

Huntsworth declared a dividend on Tuesday, March 3rd. Investors of record on Thursday, August 6th will be paid a dividend of GBX 1.85 per share on Friday, September 18th. This represents a yield of 1.74%. The ex-dividend date of this dividend is Thursday, August 6th. The official announcement can be seen at this link.
View Huntsworth's dividend history
.

What price target have analysts set for HNT?

5 equities research analysts have issued 12-month price targets for Huntsworth's shares. Their forecasts range from GBX 108 to GBX 135. On average, they expect Huntsworth's stock price to reach GBX 117.75 in the next year.
View analysts' price targets for Huntsworth
.

Who are some of Huntsworth's key competitors?

What other stocks do shareholders of Huntsworth own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Huntsworth investors own include Derwent London (DLN), Oracle (ORCL), IP Group (IPO), Legal & General Group (LGEN), London Stock Exchange Group (LSE), Petrofac (PFC), Plus500 (PLUS), Ashtead Group (AHT), Agios Pharmaceuticals (AGIO) and Celgene (CELG).

Who are Huntsworth's key executives?

Huntsworth's management team includes the following people:
  • Mr. Paul Taaffe, CEO & Director
  • Mr. Neil Garth Jones, CFO & Director (Age 53)
  • Mr. Tom Chandos, Head of Media Sector - Grayling (Age 66)
  • Mr. Martin Morrow, Company Sec.

What is Huntsworth's stock symbol?

Huntsworth trades on the London Stock Exchange (LON) under the ticker symbol "HNT."

How do I buy shares of Huntsworth?

Shares of HNT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

How big of a company is Huntsworth?

Huntsworth has a market capitalization of £0.00 and generates £264.85 million in revenue each year. Huntsworth employs 1,903 workers across the globe.

What is Huntsworth's official website?

The official website for Huntsworth is www.huntsworth.com.

How can I contact Huntsworth?

Huntsworth's mailing address is 8th Fl Holborn Gate, 26 Southampton Buildings, LONDON, WC2A 1AN, United Kingdom. The company can be reached via phone at +44-20-72248778.

This page was last updated on 9/22/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.